Anqi Lin

Central China Normal University — China

Medicine · Health Sciences

34h-index4.4kcitations240works8.82yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cancer Immunotherapy and Biomarkers(63), Ferroptosis and cancer prognosis(27), Cancer Genomics and Diagnostics(21), Radiomics and Machine Learning in Medical Imaging(21), Lung Cancer Treatments and Mutations(17)

Publications240 total

A CNN-Transformer Hybrid Network With Boundary Guidance for Mapping Cropland Field Parcels From High-Resolution Remote Sensing Imagery
IEEE Transactions on Geoscience and Remote Sensing·2026
Translational Aspects of DNA Damage Repair in Optimizing Cancer Chemotherapy
Advanced Genetics·2025Open Access
Temporal dynamics in cancer immunotherapy: the interplay between circadian rhythms, tumor microenvironment, and immune checkpoint blockade
Journal of the National Cancer Center·2025Open Access
Support for pharmacy professionals returning to practice after a break: a cross-sectional survey
International Journal of Pharmacy Practice·2025Open Access
Transforming acute exacerbations of chronic obstructive pulmonary disease (AECOPD) risk assessment: A multi‐algorithm machine learning approach for precise clinical phenotyping
View·2025Open Access
Circadian rhythms as a modulator of gut microbiota-tumor microenvironment crosstalk
Cellular and Molecular Life Sciences·2025Open Access
Insights from pharmacovigilance databases, clinical cohorts and preclinical models into VEGF(R) inhibitor-induced arthritis in cancer
Communications Medicine·2025Open Access
MendelR: A One‐Stop R Toolkit for Mendelian Randomization Analysis
Med Research·2025· 1 citedOpen Access
Medical Data as a Key Asset in the Digital Health Era: A Framework for Challenges and Strategies
iMetaMed·2025· 1 citedOpen Access
CRISPR Enabled Precision Oncology: From Gene Editing to Tumor Microenvironment Remodeling
Med Research·2025Open Access
Cloud‐Based GWAS Platform: An Innovative Solution for Efficient Acquisition and Analysis of Genomic Data
Med Research·2025· 12 citedOpen Access
Artificial Intelligence Revolutionizes Anti‐Infective Drug Discovery: From Target Identification to Lead Optimization
iMetaMed·2025· 1 citedOpen Access
Inside Front Cover: Unveiling large multimodal models in pulmonary CT: A comparative assessment of generative AI performance in lung cancer diagnostics (View 5/2025)
View·2025Open Access
A comprehensive atlas of pediatric immune checkpoint inhibitors‐related adverse events: From real‐world pharmacovigilance data to mechanistic insights
Clinical and Translational Discovery·2025Open Access
CT-HiffNet: A contour-texture hierarchical feature fusion network for cropland field parcel extraction from high-resolution remote sensing images
Computers and Electronics in Agriculture·2025· 4 citedOpen Access
Mechanistic insights into taxane-induced psychiatric adverse events: a global pharmacovigilance and experimental investigation
Molecular Psychiatry·2025· 1 citedOpen Access
A bi-directional flow weighted regression for interpreting social media sentiment identified by large language models
International Journal of Geographical Information Systems·2025· 2 cited
Microbiome meets immunotherapy: unlocking the hidden predictors of immune checkpoint inhibitors
npj Biofilms and Microbiomes·2025· 10 citedOpen Access
933P Phase Ib/II study of iza-bren (BL-B01D1), an EGFR x HER3 bispecific antibody-drug conjugate (ADC), in patients with recurrent metastatic ovarian cancer (OC)
Annals of Oncology·2025
The Future of Cancer Therapy: Nanomaterials and Tumor Microenvironment
iMetaMed·2025· 12 citedOpen Access
page 1 of 12Next →

Frequent Co-authors

Peng Luo(38), Jian Zhang(35), Quan Cheng(15), Ting Wei(11), Weiming Mou(11), Zaoqu Liu(10), Aimin Jiang(8), Lingxuan Zhu(8), Zaoqu Liu(6), Chaozheng Zhou(5), Aimin Jiang(5), Weiliang Zhu(5), Cangang Zhang(5), Wenting Luo(5), Bufu Tang(5), Linlang Guo(4), Shuofeng Yuan(4), Chang Qi(4), Hui Meng(3), Tianqi Gu(3)